NIDA’s Clinical Trials Network: An Opportunity for HIV Research in Community Substance Abuse Treatment Programs

By Tross Susan   Campbell Aimee N. C.   Calsyn Donald A.   Metsch Lisa R.   Sorensen James L.   Shoptaw Steven   Haynes Louise   Woody George E.   Malow Robert M.   Brown Lawrence S.   Feaster Daniel J.   Booth Robert E.   Mandler Raul N.   Masson Carmen   Holmes Beverly W.   Colfax Grant   Brooks Audrey J.   Hien Denise A.   Schackman Bruce R.   Korthuis P. Todd   Miele Gloria M.  

The American Journal of Drug and Alcohol Abuse, Vol. 37, Iss. 5, 2011-09 ,pp. : 283-293

Informa Healthcare

Access to resources Recommend Favorite

A Comparative Review of Health-Related Quality-of-Life Measures for Use in HIV/AIDS Clinical Trials

By Clayson Darren J.  

PharmacoEconomics, Vol. 24, Iss. 8, 2006-01 ,pp. : 751-765

Adis International

Access to resources Recommend Favorite

Four HIV vaccines are expected to enter phase I clinical trials by the end of this year

By  

Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Reporting of Deaths During Pre-Approval Clinical Trials for Advanced HIV-Infected Populations

By Johann-Liang Rosemary   James Andrea N.   Behr Virginia L.   Struble Kimberly   Birnkrant Debra B.  

Drug Safety, Vol. 28, Iss. 7, 2005-01 ,pp. : 559-564

Adis International

Access to resources Recommend Favorite

ALVAC-HIV as a prophylactic and therapeutic vaccine: highlights from over a decade of clinical trials

By Costiniuk Cecilia T   Angel Jonathan B  

Future Virology, Vol. 6, Iss. 12, 2011-12 ,pp. : 1481-1492

Future Medicine

Access to resources Recommend Favorite